|
시장보고서
상품코드
1762269
의약품 부형제 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 제형별, 기능별, 지역별 - 시장 예측(2025-2034년)Pharmaceutical Excipients Market Size, Share, Trends, Industry Analysis Report: By Product, Formulation, Functionality, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 의약품 부형제 시장 규모는 2034년까지 202억 2,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
의약품 부형제는 의약품 제제에 사용되는 불활성 성분으로, 의약품 유효성분(API)의 안정성, 생체 이용률, 적절한 약물전달을 지원합니다. 이들 물질은 충진제, 결합제, 붕괴제, 방부제, 보존제, 코팅제 등 다양한 기능을 수행하여 의약품의 효과적인 생산과 투여를 보장합니다. 부형제는 약물의 용해도를 높이고, 방출 메커니즘을 제어하고, 환자의 순응도를 향상시키는 중요한 역할을 하며, 의약품 제조에 없어서는 안 될 중요한 역할을 합니다.
의약품 부형제 시장의 성장은 의약품 생산량 증가, 약물전달 시스템의 발전, 제네릭 의약품 및 생물학적 제제에 대한 수요 증가로 인해 발생합니다. 특히 신흥 시장에서의 제약 산업의 확장은 부형제 제조업체에게 새로운 기회를 제공하고 있습니다.
다기능 부형제의 채택, 천연 유래 및 지속가능한 부형제로의 전환, 맞춤형 의료에 대한 관심 증가와 같은 제약 부형제 시장 동향은 시장 전망을 형성하고 있습니다. 또한, 부형제의 안전성과 유효성을 보장하는 엄격한 규제 가이드라인은 기술 혁신과 품질 향상을 촉진하고 있습니다. 의약품 부형제의 지속적인 발전과 헬스케어 수요 증가로 인해 의약품 부형제에 대한 수요는 꾸준히 증가할 것으로 예상됩니다.
의약품 부형제 시장 보고서 하이라이트
제품별로는 고분자, 탄수화물, 단백질 등 의약품에 광범위하게 사용되는 유기화학제품 부문이 의약품 부형제 시장에서 큰 비중을 차지하고 있습니다. 천연 유래 부형제 및 생체적합성 성분에 대한 수요 증가가 이 부문의 성장을 주도하고 있습니다.
제형별로는 정제 제형이 가장 널리 사용되는 약물전달 형태로서 제조 용이성, 환자 순응도, 긴 보관 기간 등에 힘입어 큰 성장이 예상됩니다. 비경구 제형은 생물학적 제제 및 주사제에 대한 수요 증가로 인해 가장 높은 성장세를 보이고 있습니다.
지역별로 보면 유럽은 제약 산업의 확립, 엄격한 규제 프레임워크, 제형 기술의 지속적인 발전으로 인해 2024년 의약품 부형제 시장 매출 점유율은 유럽이 독보적이었습니다.
아시아태평양 의약품 부형제 시장은 의약품 제조 확대, 의료비 지출 증가, 유리한 정부 정책에 힘입어 빠르게 성장하고 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 의약품 부형제 시장 인사이트
- 시장 현황
- 의약품 부형제 시장 역학
- 성장 촉진요인과 기회
- 국내 의약품 제조를 촉진하는 정부 이니셔티브
- 임상시험 프로세스를 강화하는 규제 개혁
- 성장 억제요인과 과제
- 규제 준수와 엄격한 품질 기준
- 성장 촉진요인과 기회
- PESTEL 분석
- 의약품 부형제 시장 애플리케이션 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 의약품 부형제 시장 : 제품별
- 주요 조사 결과
- 소개
- 무기화학제품
- 유기화학제품
제6장 세계의 의약품 부형제 시장 : 제형별
- 주요 조사 결과
- 소개
- 정제
- 캡슐
- 비경구
- 액체
- 경구
제7장 세계의 의약품 부형제 시장 : 기능별
- 주요 조사 결과
- 소개
- 블라인더
- 충전제와 희석제
- 현탁제 및 증점제
- 방부제
- 향료·감미료
- 코팅제
제8장 세계의 의약품 부형제 시장 : 지역별
- 주요 조사 결과
- 소개
- 의약품 부형제 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 제품별, 2020-2034년
- 북미 : 제형별, 2020-2034년
- 북미 : 기능별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2020-2034년
- 유럽 : 제형별, 2020-2034년
- 유럽 : 기능별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 제형별, 2020-2034년
- 아시아태평양 : 기능별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 제형별, 2020-2034년
- 중동 및 아프리카 : 기능별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 제형별, 2020-2034년
- 라틴아메리카 : 기능별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Archer Daniels Midland Company
- Ashland Global Holdings Inc.
- BASF SE
- Colorcon, Inc.
- Croda International Plc
- DFE Pharma
- DuPont de Nemours, Inc.
- Evonik Industries AG
- JRS Pharma
- Kerry Group plc
The global pharmaceutical excipients market size is expected to reach USD 20.22 billion by 2034, according to a new study by Polaris Market Research. The report "Pharmaceutical Excipients Market Size, Share, Trends, Industry Analysis Report: By Product (Inorganic Chemicals and Organic Chemicals), Formulation, Functionality, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pharmaceutical excipients are inactive components used in drug formulations to support the active pharmaceutical ingredient (API) in achieving stability, bioavailability, and proper drug delivery. These substances serve various functions, such as fillers, binders, disintegrants, preservatives, and coating agents, ensuring the effective production and administration of pharmaceuticals. Excipients play a critical role in enhancing drug solubility, controlling release mechanisms, and improving patient compliance, making them indispensable in pharmaceutical manufacturing.
The pharmaceutical excipients market growth is driven by increasing pharmaceutical production, advancements in drug delivery systems, and the rising demand for generic and biologic medicines. The expansion of the pharmaceutical industry, particularly in emerging markets, is creating new opportunities for excipient manufacturers.
Pharmaceutical excipients market trends such as the adoption of multifunctional excipients, the shift toward naturally derived and sustainable excipients, and the growing focus on personalized medicine are shaping the market landscape. Additionally, stringent regulatory guidelines ensuring excipient safety and efficacy are encouraging innovation and quality improvements. With the continuous evolution of drug formulations and increasing healthcare needs, the demand for pharmaceutical excipients is expected to remain strong.
Pharmaceutical Excipients Market Report Highlights
By product, the organic chemicals segment holds a larger pharmaceutical excipients market share due to their extensive use in drug formulations, including polymers, carbohydrates, and proteins. The increasing demand for naturally derived excipients and biocompatible ingredients is driving the growth of this segment.
By formulation, the tablets formulation segment is expected to witness significant growth as the most widely used drug delivery format, supported by ease of manufacturing, patient compliance, and long shelf life. Parenteral formulation is experiencing the highest growth due to the rising demand for biologics and injectable drugs.
By region, Europe dominated the pharmaceutical excipients market revenue share in 2024 due to its well-established pharmaceutical industry, stringent regulatory framework, and continuous advancements in drug formulation technologies.
The Asia Pacific pharmaceutical excipients market is experiencing rapid growth, driven by expanding pharmaceutical manufacturing, increasing healthcare expenditures, and favorable government policies
The pharmaceutical excipients market features several prominent companies actively contributing to the industry. These include Lubrizol Corporation; Archer Daniels Midland Company; DuPont de Nemours, Inc.; BASF SE; Evonik Industries AG; Ashland Global Holdings Inc.; Roquette Freres; Kerry Group plc; Croda International Plc; DFE Pharma; JRS Pharma; Colorcon, Inc.; MEGGLE GmbH & Co. KG; Wacker Chemie AG; and Associated British Foods plc.
Polaris Market Research has segmented the pharmaceutical excipients market report based on product, formulation, functionality, and region:
By Product Outlook (Revenue-USD Billion, 2020-2034)
Inorganic Chemicals
Organic Chemicals
By Formulation Outlook (Revenue-USD Billion, 2020-2034)
Tablets Formulation
Capsules Formulation
Parental Formulation
Liquid Formulation
Oral Formulation
By Functionality Outlook (Revenue-USD Billion, 2020-2034)
Blinders
Fillers & Diluents
Suspending & Viscosity agents
Preservatives
Flavoring Agents & Sweeteners
Coating Agents
By Regional Outlook (Revenue-USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Pharmaceutical Excipients Market Insights
- 4.1. Pharmaceutical Excipients Market - Market Snapshot
- 4.2. Pharmaceutical Excipients Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Government Initiatives Promoting Domestic Pharmaceutical Manufacturing
- 4.2.1.2. Regulatory Reforms Enhancing Clinical Trial Processes
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory Compliance and Stringent Quality Standards
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Pharmaceutical Excipients Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Pharmaceutical Excipients Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 5.3. Inorganic Chemicals
- 5.3.1. Global Pharmaceutical Excipients Market, by Inorganic Chemicals, by Region, 2020-2034 (USD Billion)
- 5.4. Organic Chemicals
- 5.4.1. Global Pharmaceutical Excipients Market, by Organic Chemicals, by Region, 2020-2034 (USD Billion)
6. Global Pharmaceutical Excipients Market, by Formulation
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 6.3. Tablets Formulation
- 6.3.1. Global Pharmaceutical Excipients Market, by Tablets Formulation, by Region, 2020-2034 (USD Billion)
- 6.4. Capsules Formulation
- 6.4.1. Global Pharmaceutical Excipients Market, by Capsules Formulation, by Region, 2020-2034 (USD Billion)
- 6.5. Parental Formulation
- 6.5.1. Global Pharmaceutical Excipients Market, by Parental Formulation, by Region, 2020-2034 (USD Billion)
- 6.6. Liquid Formulation
- 6.6.1. Global Pharmaceutical Excipients Market, by Liquid Formulation, by Region, 2020-2034 (USD Billion)
- 6.7. Oral Formulation
- 6.7.1. Global Pharmaceutical Excipients Market, by Oral Formulation, by Region, 2020-2034 (USD Billion)
7. Global Pharmaceutical Excipients Market, by Functionality
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 7.3. Blinders
- 7.3.1. Global Pharmaceutical Excipients Market, by Blinders, by Region, 2020-2034 (USD Billion)
- 7.4. Fillers & Diluents
- 7.4.1. Global Pharmaceutical Excipients Market, by Fillers & Diluents, by Region, 2020-2034 (USD Billion)
- 7.5. Suspending & Viscosity agents
- 7.5.1. Global Pharmaceutical Excipients Market, by Suspending & Viscosity agents, by Region, 2020-2034 (USD Billion)
- 7.6. Preservatives
- 7.6.1. Global Pharmaceutical Excipients Market, by Preservatives, by Region, 2020-2034 (USD Billion)
- 7.7. Flavoring agents & Sweeteners
- 7.7.1. Global Pharmaceutical Excipients Market, by Flavoring agents & Sweeteners, by Region, 2020-2034 (USD Billion)
- 7.8. Coating agents
- 7.8.1. Global Pharmaceutical Excipients Market, by Coating agents, by Region, 2020-2034 (USD Billion)
8. Global Pharmaceutical Excipients Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Pharmaceutical Excipients Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Pharmaceutical Excipients Market - North America
- 8.3.1. North America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. North America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.3. North America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.3.4. Pharmaceutical Excipients Market - U.S.
- 8.3.4.1. U.S.: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.3.5. Pharmaceutical Excipients Market - Canada
- 8.3.5.1. Canada: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4. Pharmaceutical Excipients Market - Europe
- 8.4.1. Europe: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.2. Europe: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.3. Europe: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.4. Pharmaceutical Excipients Market - UK
- 8.4.4.1. UK: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.5. Pharmaceutical Excipients Market - France
- 8.4.5.1. France: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.5.2. France: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.5.3. France: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.6. Pharmaceutical Excipients Market - Germany
- 8.4.6.1. Germany: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.7. Pharmaceutical Excipients Market - Italy
- 8.4.7.1. Italy: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.8. Pharmaceutical Excipients Market - Spain
- 8.4.8.1. Spain: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.9. Pharmaceutical Excipients Market - Netherlands
- 8.4.9.1. Netherlands: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.10. Pharmaceutical Excipients Market - Russia
- 8.4.10.1. Russia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.4.11. Pharmaceutical Excipients Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5. Pharmaceutical Excipients Market - Asia Pacific
- 8.5.1. Asia Pacific: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.4. Pharmaceutical Excipients Market - China
- 8.5.4.1. China: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.4.2. China: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.4.3. China: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.5. Pharmaceutical Excipients Market - India
- 8.5.5.1. India: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.5.2. India: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.5.3. India: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.6. Pharmaceutical Excipients Market - Malaysia
- 8.5.6.1. Malaysia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.7. Pharmaceutical Excipients Market - Japan
- 8.5.7.1. Japan: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.8. Pharmaceutical Excipients Market - Indonesia
- 8.5.8.1. Indonesia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.9. Pharmaceutical Excipients Market - South Korea
- 8.5.9.1. South Korea: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.10. Pharmaceutical Excipients Market - Australia
- 8.5.10.1. Australia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.5.11. Pharmaceutical Excipients Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.6. Pharmaceutical Excipients Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.6.4. Pharmaceutical Excipients Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.6.5. Pharmaceutical Excipients Market - UAE
- 8.6.5.1. UAE: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.6.6. Pharmaceutical Excipients Market - Israel
- 8.6.6.1. Israel: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.6.7. Pharmaceutical Excipients Market - South Africa
- 8.6.7.1. South Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.6.8. Pharmaceutical Excipients Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.7. Pharmaceutical Excipients Market - Latin America
- 8.7.1. Latin America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.7.4. Pharmaceutical Excipients Market - Mexico
- 8.7.4.1. Mexico: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.7.5. Pharmaceutical Excipients Market - Brazil
- 8.7.5.1. Brazil: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.7.6. Pharmaceutical Excipients Market - Argentina
- 8.7.6.1. Argentina: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
- 8.7.7. Pharmaceutical Excipients Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Archer Daniels Midland Company
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Ashland Global Holdings Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. BASF SE
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Colorcon, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Croda International Plc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. DFE Pharma
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. DuPont de Nemours, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Evonik Industries AG
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. JRS Pharma
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Kerry Group plc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
